We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Adverse Events Linked to Mylan's Fentanyl Are Minimal, Company Says
Adverse Events Linked to Mylan's Fentanyl Are Minimal, Company Says
July 26, 2005
Only a “very small number” of adverse events have been reported by patients using Mylan’s fentanyl pain patch — the generic version of Johnson & Johnson’s (J&J) Duragesic, for which the FDA recently issued a public health advisory — according to Mylan’s chief executive.